Cambridge Investment Research Advisors, Inc. Viatris Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 138,728 shares of VTRS stock, worth $1.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

138,728

Previous 159,236 12.88%

Holding current value

$1.72 Million

Previous $1.69 Million 4.84%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$10.32 - $12.13 $211,642 - $248,762	-20,508 Reduced 12.88%	138,728 $1.61 Million
Q2 2024 Jul 26, 2024	SELL	$10.05 - $12.02 $32,943 - $39,401	-3,278 Reduced 2.02%	159,236 $1.69 Million
Q1 2024 Apr 24, 2024	SELL	$11.27 - $13.53 $57,206 - $68,678	-5,076 Reduced 3.03%	162,514 $1.94 Million
Q4 2023 Feb 09, 2024	SELL	$8.77 - $10.85 $104,810 - $129,668	-11,951 Reduced 6.66%	167,590 $1.82 Million
Q3 2023 Oct 24, 2023	BUY	$9.59 - $11.35 $50,107 - $59,303	5,225 Added 3.0%	179,541 $1.77 Million
Q2 2023 Jul 13, 2023	BUY	$9.02 - $10.29 $235,232 - $268,352	26,079 Added 17.59%	174,316 $1.74 Million
Q1 2023 May 11, 2023	BUY	$9.2 - $12.26 $26,532 - $35,357	2,884 Added 1.98%	148,237 $1.43 Million
Q4 2022 Feb 08, 2023	SELL	$8.72 - $11.56 $396,576 - $525,737	-45,479 Reduced 23.83%	145,353 $1.62 Million
Q3 2022 Oct 17, 2022	BUY	$8.48 - $11.13 $202,383 - $265,628	23,866 Added 14.29%	190,832 $1.63 Million
Q2 2022 Jul 13, 2022	BUY	$9.95 - $12.27 $47,600 - $58,699	4,784 Added 2.95%	166,966 $1.75 Million
Q1 2022 May 12, 2022	BUY	$9.81 - $15.4 $219,734 - $344,944	22,399 Added 16.02%	162,182 $1.76 Million
Q4 2021 Feb 03, 2022	SELL	$12.09 - $14.68 $40,658 - $49,368	-3,363 Reduced 2.35%	139,783 $1.89 Million
Q3 2021 Nov 02, 2021	SELL	$13.25 - $15.13 $792,800 - $905,288	-59,834 Reduced 29.48%	143,146 $1.94 Million
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $81,308 - $101,244	-6,269 Reduced 3.0%	202,980 $2.9 Million
Q1 2021 May 07, 2021	BUY	$13.59 - $18.54 $37,141 - $50,669	2,733 Added 1.32%	209,249 $2.92 Million
Q4 2020 Feb 04, 2021	BUY	$14.3 - $18.74 $2.95 Million - $3.87 Million	206,516 New	206,516 $3.87 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Viatris Inc Transaction History